PMID- 29176662 OWN - NLM STAT- MEDLINE DCOM- 20180828 LR - 20181127 IS - 2044-5385 (Electronic) IS - 2044-5385 (Linking) VI - 7 IP - 12 DP - 2017 Nov 27 TI - Minimal residual disease by either flow cytometry or cytogenetics prior to an allogeneic hematopoietic stem cell transplant is associated with poor outcome in acute myeloid leukemia. PG - 634 LID - 10.1038/s41408-017-0007-x [doi] LID - 634 AB - Relapsed acute myeloid leukemia (AML) is a significant challenge after allogeneic hematopoietic cell transplant (HCT). Multiparameter flow cytometry (MFC), conventional cytogenetics (CG), and fluorescence in situ hybridization (FISH) are routinely performed on bone marrow specimens prior to HCT to assess disease status. We questioned the extent by which pre-HCT evidence of minimal residual disease (MRD) detected by these standard assays, corresponded with post-HCT relapse. We conducted a single center, retrospective study of 166 AML patients who underwent HCT. Thirty-eight of one hundred sixty-six (23%) patients in complete remission (CR) or CR with incomplete count recovery (CRi) had MRD detectable by MFC, CG, or FISH. MRD was more frequently seen in patients with poor risk karyotype at diagnosis (P = 0.011). MRD-negative patients (MRD(neg)) had significantly longer overall survival (OS) and relapse-free survival than patients who were MRD positive (MRD(pos)) (P = 0.002 and 0.013, respectively). In patients with MRD(pos) prior to HCT, the presence of acute graft vs. host disease (GVHD) (grade >/= 2) or chronic GVHD significantly improved progression free survival (PFS) (hazard ratio (HR) = 0.053 (95% confidence interval (CI): 0.01-0.279), P = 0.0005) and OS (HR = 0.211 (95% CI: 0.081-0.547), P = 0.0014). FAU - Norkin, Maxim AU - Norkin M AD - Division of Hematology and Oncology, Department of Internal Medicine, College of Medicine, University of Florida, Gainesville, FL, USA. norkinm@ufl.edu. FAU - Katragadda, Lakshmikanth AU - Katragadda L AD - Division of Hematology and Oncology, Department of Internal Medicine, College of Medicine, University of Florida, Gainesville, FL, USA. FAU - Zou, Fei AU - Zou F AD - Department of Biostatistics, College of Medicine, University of Florida, Gainesville, FL, USA. FAU - Xiong, Sican AU - Xiong S AD - Department of Biostatistics, College of Medicine, University of Florida, Gainesville, FL, USA. FAU - Chang, Myron AU - Chang M AD - Department of Biostatistics, College of Medicine, University of Florida, Gainesville, FL, USA. FAU - Dai, Yunfeng AU - Dai Y AD - Department of Biostatistics, College of Medicine, University of Florida, Gainesville, FL, USA. FAU - Hsu, Jack W AU - Hsu JW AD - Division of Hematology and Oncology, Department of Internal Medicine, College of Medicine, University of Florida, Gainesville, FL, USA. FAU - Moreb, Jan S AU - Moreb JS AD - Division of Hematology and Oncology, Department of Internal Medicine, College of Medicine, University of Florida, Gainesville, FL, USA. FAU - Leather, Helen AU - Leather H AD - Division of Hematology and Oncology, Department of Internal Medicine, College of Medicine, University of Florida, Gainesville, FL, USA. FAU - Murthy, Hemant S AU - Murthy HS AD - Division of Hematology and Oncology, Department of Internal Medicine, College of Medicine, University of Florida, Gainesville, FL, USA. FAU - Farhadfar, Nosha AU - Farhadfar N AD - Division of Hematology and Oncology, Department of Internal Medicine, College of Medicine, University of Florida, Gainesville, FL, USA. FAU - Li, Ying AU - Li Y AD - Department of Pathology, College of Medicine, University of Florida, Gainesville, FL, USA. FAU - Hromas, Robert AU - Hromas R AUID- ORCID: 0000-0002-1916-6276 AD - Division of Hematology and Oncology, Department of Internal Medicine, College of Medicine, University of Florida, Gainesville, FL, USA. FAU - Brown, Randy A AU - Brown RA AD - Division of Hematology and Oncology, Department of Internal Medicine, College of Medicine, University of Florida, Gainesville, FL, USA. FAU - Cogle, Christopher R AU - Cogle CR AD - Division of Hematology and Oncology, Department of Internal Medicine, College of Medicine, University of Florida, Gainesville, FL, USA. FAU - Wingard, John R AU - Wingard JR AD - Division of Hematology and Oncology, Department of Internal Medicine, College of Medicine, University of Florida, Gainesville, FL, USA. LA - eng PT - Journal Article DEP - 20171127 PL - United States TA - Blood Cancer J JT - Blood cancer journal JID - 101568469 SB - IM MH - Adult MH - Aged MH - Cytogenetic Analysis MH - Disease-Free Survival MH - Female MH - Flow Cytometry MH - Graft vs Host Disease MH - *Hematopoietic Stem Cell Transplantation MH - Humans MH - Kaplan-Meier Estimate MH - Leukemia, Myeloid, Acute/mortality/*pathology/*surgery MH - Male MH - Middle Aged MH - Neoplasm Recurrence, Local/mortality/pathology/surgery MH - Neoplasm, Residual/mortality/*pathology/*surgery MH - Prognosis MH - Proportional Hazards Models MH - Retrospective Studies MH - Transplantation, Homologous MH - Treatment Outcome PMC - PMC5802525 COIS- COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER'S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. EDAT- 2017/11/28 06:00 MHDA- 2018/08/29 06:00 PMCR- 2017/11/27 CRDT- 2017/11/28 06:00 PHST- 2017/08/20 00:00 [received] PHST- 2017/08/25 00:00 [accepted] PHST- 2017/11/28 06:00 [entrez] PHST- 2017/11/28 06:00 [pubmed] PHST- 2018/08/29 06:00 [medline] PHST- 2017/11/27 00:00 [pmc-release] AID - 10.1038/s41408-017-0007-x [pii] AID - 7 [pii] AID - 10.1038/s41408-017-0007-x [doi] PST - epublish SO - Blood Cancer J. 2017 Nov 27;7(12):634. doi: 10.1038/s41408-017-0007-x.